Skip to main content
. 2014 Sep 14;20(34):12007–12017. doi: 10.3748/wjg.v20.i34.12007

Table 3.

Circulating microRNAs as diagnostic biomarkers

Ref. Sample Method (normalization) MiRNA Clinical application
Li et al[74] (CN) 80 EGC/70 C plasma real-time qRT-PCR(U6, U44) miR-199-3p Early detection of GC
Rotkrua et al[72] (JP) 6 DCKO mice with DGC/6 C tissue miRNA microarray and miR-103, miR-107, Early detection of DGC
21 DCKO mice with DGC/23 C serum TaqMan qRT-PCR (cel-miR-39) miR-194 and miR-210
Li et al[75] (CN) 230 GC/130 C and miRNA microarray and miR-199-3p GC detection
20 gastric precancerous plasma real-time qRT-PCR (U6, U44)
Cai et al[76] (CN) 90 GC(70A, 16M, 3S, 1SC)/90 C plasma qRT-PCR (cel-miR-39) miR-106b, miR-20a, Early detection of GC
and miR-221
Li et al[91] (CN) 8 GC/8 C tissue qRT-PCR (U6, cel-miR-39) miR-223, miR-21 GC detection
70 GC(56A, 13M, 1S)/70 C plasma and miR-218
Wang et al[92] (CN) 174 solid cancers/39 C serum qRT-PCR (miR-16) miR-21 Detection of some solid cancers
Song et al[93] (CN) 82 GC(71A, 3S, 1SC)/46 DYS/128 C serum TaqMan low-density array miR-221, miR-376c Early detection of GC
and TaqMan qRT-PCR (cel-miR-39) and miR-744
Konishi et al[94] (JP) 56 GC/30 C plasma miRNA microarray miR-451 and miR-486 Screening GC
and qRT-PCR (U6)
Liu et al[77] (CN) 61 GC(A, M)/61 C serum miRNA microarray miR-378 Early detection of GC
and real-time qRT-PCR (U6)
Liu et al[82] (CN) 164 GC/127 C serum Solexa sequencing miR-1, miR-20a, miR-27a, GC detection
and qRT-PCR (the serum volume) miR-34 and miR-423-5p
Tsujiura et al[73] (JP) 8 GC/8 C tissue qRT-PCR (RNU6B) miR-17-5p, miR-21, miR-106a, GC detection
79 GC/30 C plasma miR-106b and let-7a
Gorur et al[95] (TR) 20 GC/190 C plasma real-time qPCR (global means) miR-195-5p Early detection of GC
Wang et al[54] (CN) 80 gastric adenocarcinomas/40 peritumoral tissues real-time qRT-PCR (U6) let-7a GC detection
80 gastric adenocarcinomas/45 C serum

C: Control; DCKO: Double-conditional knockout; DGC: Diffuse-type gastric cancer; DYS: Dysplasia; GC: Gastric cancer; LN, lymph node; A: Adenocarcinoma; M: Mucinous carcinoma; S: Signet-ring cell carcinoma; SC: Squamous cell carcinoma.